serine has been researched along with azilsartan in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukuda, D; Masuzaki, H; Matsumoto, S; Sata, M; Shimabukuro, M; Soeki, T; Yamakawa, K | 1 |
1 other study(ies) available for serine and azilsartan
Article | Year |
---|---|
Azilsartan, an angiotensin II type 1 receptor blocker, restores endothelial function by reducing vascular inflammation and by increasing the phosphorylation ratio Ser(1177)/Thr(497) of endothelial nitric oxide synthase in diabetic mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Diabetes Mellitus, Experimental; Endothelium, Vascular; Male; Mice; Mice, Inbred C57BL; Nitric Oxide Synthase Type III; Organ Culture Techniques; Oxadiazoles; Phosphorylation; Serine; Threonine; Vasculitis; Vasodilation | 2014 |